mRNA Medicine

SAN DIEGO — September 18, 2026 Arcturus Therapeutics announced plans to provide an update on its ARCT-810 Phase 2...

LONDON, July 16, 2026 GSK plc has officially completed its acquisition of Nuvalent, Inc., marking a major strategic expansion...

CAMBRIDGE, Mass., July 16, 2026 Moderna, Inc. has announced the first participant has been dosed in its Phase 1...